0.0041USD+2.50%Mkt Cap: 173726 $P/E: 0.001d ago
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pha…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap173.73K $
Enterprise Value-4.17M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)1.91M $
Revenue/Share—
Last Price0.0041 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.10
EPS (TTM)6.64
EPS (Forward)-1.09
52W Range
0.00206% of range0.0380
52W High0.0380 USD
52W Low0.0020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE66.66%
ROA37.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.73M $
CapEx (TTM)—
FCF Margin—
FCF Yield-12262.24%
Net Debt-4.35M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.68
Quick Ratio1.66
Book Value/Sh0.0420 USD
Cash/Share0.1030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateMay 1, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.37M
Float28.93M
Insiders24.08%
Institutions10.24%
Short Interest
Short Ratio0.2d
Short % Float25.07%
Short % Out.24.06%
Shares Short493.83K
Short (prev mo.)59.27K
Technical
SMA 500.0061 (-32.3%)
SMA 2000.0102 (-59.9%)
Beta1.87
S&P 52W Chg20.25%
Avg Vol (30d)63.45K
Avg Vol (10d)154.62K
Technical Indicators
RSI (14)37.1
MACD-0.0005
MACD Signal-0.0004
MACD Hist.-0.0001
BB Upper0.0072 USD
BB Middle0.0053 USD
BB Lower0.0034 USD
BB Width70.85%
ATR (14)0.0009 USD
Vol Ratio (20d)0.15x